These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4033071)

  • 1. Detection and confirmation of urinary cannabinoids.
    Sutheimer CA; Yarborough R; Hepler BR; Sunshine I
    J Anal Toxicol; 1985; 9(4):156-60. PubMed ID: 4033071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P; Griffiths WC; Camara P; Audette L; Rosner M
    Ann Clin Lab Sci; 1989; 19(2):133-8. PubMed ID: 2546480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of six cannabinoid metabolite assays.
    Frederick DL; Green J; Fowler MW
    J Anal Toxicol; 1985; 9(3):116-20. PubMed ID: 3892161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods.
    Kogan MJ; Al Razi J; Pierson DJ; Willson NJ
    J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of EMIT cannabinoid assay results by bonded phase adsorption with thin layer chromatography.
    Willson NJ; Kogan MJ; Pierson DJ; Newman E
    J Toxicol Clin Toxicol; 1983 Jul; 20(5):465-73. PubMed ID: 6366244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitation of cannabinoid immunoassays? A reexamination of the EMIT 20-ng/mL assay.
    Haver VM; Romson JL; Sadrzadeh SM
    J Anal Toxicol; 1991; 15(2):98-100. PubMed ID: 1646909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations on radioimmunoassay, fluorescence polarization immunoassay, and enzyme immunoassay of cannabis metabolites with gas chromatography/mass spectrometry analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine specimens.
    Weaver ML; Gan BK; Allen E; Baugh LD; Liao FY; Liu RH; Langner JG; Walia AS; Cook LF
    Forensic Sci Int; 1991; 49(1):43-56. PubMed ID: 1851715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary cannabinoid analysis: comparison of four immunoassays with gas chromatography-mass spectrometry.
    Altunkaya D; Clatworthy AJ; Smith RN; Start IJ
    Forensic Sci Int; 1991; 50(1):15-22. PubMed ID: 1937304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a TLC method with EMIT and GC/MS for detection of cannabinoids in urine.
    Foltz RL; Sunshine I
    J Anal Toxicol; 1990; 14(6):375-8. PubMed ID: 2087098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine cannabinoid analysis: an integrated multi-method approach.
    Black DL; Goldberger BA; Isenschmid DS; White SM; Caplan YH
    J Anal Toxicol; 1984; 8(5):224-7. PubMed ID: 6389979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunoassays for cannabinoids in urine.
    Irving J; Leeb B; Foltz RL; Cook CE; Bursey JT; Willette RE
    J Anal Toxicol; 1984; 8(4):192-6. PubMed ID: 6471820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False negative GC/MS assay for carboxy THC due to ibuprofen interference.
    Brunk SD
    J Anal Toxicol; 1988; 12(5):290-1. PubMed ID: 2852278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results.
    Huestis MA; Mitchell JM; Cone EJ
    Clin Chem; 1994 May; 40(5):729-33. PubMed ID: 8174244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood.
    Moody DE; Rittenhouse LF; Monti KM
    J Anal Toxicol; 1992; 16(5):297-301. PubMed ID: 1338217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary cannabinoids in monitoring abstinence in a drug abuse treatment program.
    Schwartz RH; Willette RE; Hayden GF; Bogema S; Thorne MM; Hicks J
    Arch Pathol Lab Med; 1987 Aug; 111(8):708-11. PubMed ID: 3307687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a high-performance liquid chromatography method for the evaluation of niflumic acid cross-reactivity of two commercial immunoassays for cannabinoids in urine.
    Kovatsi L; Pouliopoulos A; Papadaki A; Samanidou V; Tsoukali H
    J Anal Toxicol; 2010 May; 34(4):229-32. PubMed ID: 20465870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of the cannabinoid metabolite and phencyclidine EMIT d.a.u. assays.
    Allen LV; Stiles ML
    J Anal Toxicol; 1988; 12(1):45-7. PubMed ID: 3280873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a radioimmunoassay (125I) kit for cannabinoid metabolites in urine and whole blood.
    Childs PS; McCurdy HH
    J Anal Toxicol; 1984; 8(5):220-3. PubMed ID: 6503225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
    Moody DE; Monti KM; Crouch DJ
    J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.